Résumé Contexte Le Réseau canadien pour les traitements de l'humeur et de l'anxiété
(CANMAT) a publié les dernières lignes directrices cliniques pour le traitement du trouble …

Background Many studies have recently been conducted to assess the antidepressant
efficacy of glutamate modification in mood disorders. This is an update of a review first …

Background Recently intermittent theta burst stimulation (iTBS) proved to be non-inferior to
conventional repetitive transcranial magnetic stimulation (10 Hz rTMS) in unipolar …

Abstract Background Borderline Personality Disorder (BPD) and Major Depressive Disorder
(MDD) are two clinical conditions that often co-occur, sharing several neurobiological …

Depression is a disease with several molecular mechanisms involved, such as problems in
the serotonergic pathway. This disease is very complex and prevalent, and thus important to …

Introduction The purpose of this update is to add newly approved nomenclatures and
treatments as well as treatments yet to be approved in major depressive disorder, thus …

Introduction The effect of concomitant medication on repetitive transcranial magnetic
stimulation (rTMS) outcomes in depression remains understudied. Recent analyses show …

The British Association for Psychopharmacology course on child and adolescent
psychopharmacology has been run for more than 20 years and is currently a very popular …

Purpose The aim of the study was to appraise the current evidence on the optimal serum
level for lamotrigine (LAM) in the treatment of mood disorders (major depressive disorder …

Approximately 1 in 20 Canadians are diagnosed with it each year, and it is the second
highest cause of disability worldwide. 1 Nonresponse to treatment is common, with response …